Nu Skin Enterprises (NYSE:NUS) had its price objective trimmed by Canaccord Genuity from $86.00 to $78.00 in a report released on Tuesday, Stock Ratings Network.com reports.
Shares of Nu Skin Enterprises (NYSE:NUS) traded down 1.20% on Tuesday, hitting $77.70. The stock had a trading volume of 730,200 shares. Nu Skin Enterprises has a one year low of $40.32 and a one year high of $140.50. The stock’s 50-day moving average is $82.10 and its 200-day moving average is $103.. The company has a market cap of $4.622 billion and a P/E ratio of 16.09. Nu Skin Enterprises also saw some unusual options trading activity on Monday. Investors purchased 6,848 put options on the company. This is an increase of approximately 324% compared to the typical volume of 1,617 put options.
Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Monday, March 3rd. The company reported $2.02 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.99 by $0.03. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter last year, the company posted $0.97 earnings per share. Nu Skin Enterprises’s revenue was up 82.3% compared to the same quarter last year. On average, analysts predict that Nu Skin Enterprises will post $6.24 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, March 26th. Shareholders of record on Friday, March 14th will be paid a dividend of $0.345 per share. This represents a $1.38 annualized dividend and a dividend yield of 1.75%. The ex-dividend date is Wednesday, March 12th. This is a positive change from Nu Skin Enterprises’s previous quarterly dividend of $0.30.
NUS has been the subject of a number of other recent research reports. Analysts at Bank of America raised their price target on shares of Nu Skin Enterprises from $2.00 to $85.00 in a research note on Tuesday. Separately, analysts at Wedbush cut their price target on shares of Nu Skin Enterprises to $105.00 in a research note on Monday. Finally, analysts at Ned Davis Research upgraded shares of Nu Skin Enterprises from a neutral rating to a buy rating in a research note on Monday, February 24th. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Nu Skin Enterprises has an average rating of Buy and an average price target of $102.10.
Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.
To view Canaccord Genuity’s full report, visit Canaccord Genuity’s official website.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.